Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Bacik

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Statistics in Medicine|February 19, 2003
Methods for categorizing a prognostic variable in a multivariable settingMadhu Mazumdar, Alex Smith, Jennifer Bacik
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Prognostic factors for survival of patients with stage IV renal cell carcinoma: memorial sloan-kettering cancer center experienceRobert J Motzer, Jennifer Bacik, Madhu Mazumdar
Cancer|August 24, 2005
Presentation and subsequent publication rates of phase I oncology clinical trialsLuis H Camacho, Jennifer Bacik, Alexander Cheung, et al.
Health and Quality of Life Outcomes|September 28, 2006
A brief symptom index for advanced renal cell carcinomaDavid T Eton, David Cella, Jennifer Bacik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinomaRobert J Motzer, Jennifer Bacik, Barbara A Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histologyRobert J Motzer, Jennifer Bacik, Tania Mariani, et al.
Investigational New Drugs|October 28, 2003
Phase II trial of ZD1839 (IRESSA) in patients with advanced renal cell carcinomaBeverly Drucker, Jennifer Bacik, Michelle Ginsberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Prognostic factors for survival in previously treated patients with metastatic renal cell carcinomaRobert J Motzer, Jennifer Bacik, Lawrence H Schwartz, et al.
Urology|October 11, 2003
Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcomeJames M McKiernan, Robert J Motzer, Dean F Bajorin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Phase II trial of thalidomide for patients with advanced renal cell carcinomaRobert J Motzer, William Berg, Michelle Ginsberg, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Statistics in Medicine|February 19, 2003
Methods for categorizing a prognostic variable in a multivariable settingMadhu Mazumdar, Alex Smith, Jennifer Bacik
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Prognostic factors for survival of patients with stage IV renal cell carcinoma: memorial sloan-kettering cancer center experienceRobert J Motzer, Jennifer Bacik, Madhu Mazumdar
Cancer|August 24, 2005
Presentation and subsequent publication rates of phase I oncology clinical trialsLuis H Camacho, Jennifer Bacik, Alexander Cheung, et al.
Health and Quality of Life Outcomes|September 28, 2006
A brief symptom index for advanced renal cell carcinomaDavid T Eton, David Cella, Jennifer Bacik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinomaRobert J Motzer, Jennifer Bacik, Barbara A Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histologyRobert J Motzer, Jennifer Bacik, Tania Mariani, et al.
Investigational New Drugs|October 28, 2003
Phase II trial of ZD1839 (IRESSA) in patients with advanced renal cell carcinomaBeverly Drucker, Jennifer Bacik, Michelle Ginsberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Prognostic factors for survival in previously treated patients with metastatic renal cell carcinomaRobert J Motzer, Jennifer Bacik, Lawrence H Schwartz, et al.
Urology|October 11, 2003
Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcomeJames M McKiernan, Robert J Motzer, Dean F Bajorin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Phase II trial of thalidomide for patients with advanced renal cell carcinomaRobert J Motzer, William Berg, Michelle Ginsberg, et al.
Pageof 3